Stock listing
A403QV Stock Price, News, Filings & Events — Biophytis Sa
Selected listing: A403QV · LSX · EUR · DE
This page tracks Biophytis Sa's A403QV:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A403QV:LSX. A403QV:LSX is the stock-level entry point for investors researching Biophytis Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A403QV:LSX
- Asset type
- Stock
- Market cap
- $17.6M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- Exchange
- LSX
- Currency
- EUR
Biophytis Sa A403QV:LSX stock context
This page tracks Biophytis Sa's A403QV:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A403QV:LSX. A403QV:LSX is the stock-level entry point for investors researching Biophytis Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Biophytis Sa
Biophytis S A : ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
September 11, 2026
Biophytis S A : to evaluate BIO101’s potential to limit weight regain in its OBA clinical study in obesity
September 9, 2026
Biophytis S A : strengthens its financial position and extends its cash runway into Q1 2027
August 31, 2026
Biophytis S A : INFORMATION ON ANNUAL FINANCIAL STATEMENTS
April 29, 2026
Biophytis S A : ANNOUNCES COMPLETION OF OVER €2.0 MILLION CAPITAL INCREASE AND THE REPAYMENT OF ALL VARIABLE PRICE CONVERTIBLE DEBT
March 11, 2026
Research Biophytis Sa
Biophytis Sa investor report
Review AI stock analysis and investor report context for A403QV:LSX.
Biophytis Sa company profile
View the public company page for Biophytis Sa on 6ix.
Biophytis Sa news
Read company news and market updates connected to Biophytis Sa.
Biophytis Sa investor events
Find investor webinars, events, and replay context for Biophytis Sa.
Alternate listings
ALBPS:EURONEXT
FR · EUR
Alternate listing for Biophytis Sa; the primary context on this page is A403QV:LSX.
0D1W:LSE
GB · EUR
Alternate listing for Biophytis Sa; the primary context on this page is A403QV:LSX.
BPTSY:OTC
US · USD
Alternate listing for Biophytis Sa; the primary context on this page is A403QV:LSX.
A403QV:LS
DE · EUR
Alternate listing for Biophytis Sa; the primary context on this page is A403QV:LSX.
6XB3:GETTEX
DE · EUR
Alternate listing for Biophytis Sa; the primary context on this page is A403QV:LSX.
6XB3:FWB
DE · EUR
Alternate listing for Biophytis Sa; the primary context on this page is A403QV:LSX.
6XB3:MUN
DE · EUR
Alternate listing for Biophytis Sa; the primary context on this page is A403QV:LSX.
ALBPSP:TURQUOISE
GB · EUR
Alternate listing for Biophytis Sa; the primary context on this page is A403QV:LSX.
6XB3:SWB
DE · EUR
Alternate listing for Biophytis Sa; the primary context on this page is A403QV:LSX.